美国偏头痛人群中阿片类药物使用特征:CaMEO研究结果
基于CaMEO横断面互联网研究,分析2,388例使用处方急性治疗药物的偏头痛患者,36.3%报告当前使用或备有阿片类药物。阿片使用与男性、共病多、头痛负担重、生活质量差及焦虑抑郁等因素相关,且自我报告医生诊断偏头痛/慢性偏头痛与使用可能性降低相关。
要点
- 使用急性处方药的偏头痛患者中36.3%使用或备有阿片类药物。
- 阿片使用与更多共病、更高头痛负担和更差生活质量相关。
- 男性、焦虑、抑郁、心血管共病及急诊就诊等因素与阿片使用相关。
核心结论
- 在使用急性处方药治疗偏头痛的受访者中,超过三分之一使用或备有阿片类药物,与指南相悖。
研究设计与样本
- CaMEO研究为横断面、纵向互联网研究,纳入867例报告使用阿片类药物治疗偏头痛的个体,比较阿片使用者和非使用者。
主要发现
- 2,388例使用处方急性治疗药物的偏头痛受访者中,36.3%报告当前使用或备有阿片类药物。
- 当前阿片使用者比非使用者有显著更多共病、更大头痛相关负担和更差生活质量。
- 回归模型显示与阿片使用显著相关的因素包括男性、体重指数、异常性疼痛、每月头痛频率增加、Total Pain Index评分(除外头面颈部/肩部)、焦虑、抑郁、≥1种心血管共病及过去6个月因头痛急诊/紧急护理就诊。
- 自我报告医生诊断的偏头痛/慢性偏头痛与阿片使用可能性显著降低相关。
临床怎么用
- 临床中应关注偏头痛患者阿片类药物的使用或备用情况,尤其合并焦虑、抑郁、心血管共病及高频头痛者。
局限性
- 该分析无法区分风险因素与阿片使用后果,需进一步研究以指导减少偏头痛中阿片类药物不当使用的策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine the prevalence of and risk factors associated with opioid use in the treatment of migraine, we examined demographics and clinical characteristics of 867 individuals who reported using opioids for the treatment of migraine. METHODS: We analyzed data from the CaMEO study (Chronic Migraine Epidemiology and Outcomes), a cross-sectional, longitudinal, Internet study, to compare sociodemographics, clinical characteristics, and migraine burden/disability of opioid users vs nonusers. Covariates were entered as categorical or continuous variables. Factors associated with opioid use were identified using nested, multivariable binary logistic regression models. RESULTS: Of 2,388 respondents with migraine using prescription medications for acute treatment, 36.3% reported that they currently used or kept on hand opioid medications to treat headaches. Current opioid users had significantly more comorbidities, greater headache-related burden, and poorer quality of life than nonusers. Regression models revealed factors significantly associated with opioid use, including male sex, body mass index, allodynia, increasing monthly headache frequency, Total Pain Index score (excluding head, face, neck/shoulder), anxiety, depression, ≥1 cardiovascular comorbidity, and emergency department/urgent care use for headache in the past 6 months. Self-reported physician-diagnosed migraine/chronic migraine was associated with significantly decreased likelihood of opioid use. CONCLUSIONS: Of respondents who were using acute prescription medications for migraine, more than one-third used or kept opioids on hand, contrary to guidance. This analysis could not distinguish risk factors from consequences of opioid use; thus further research is needed to guide the development of strategies for reducing the inappropriate use of opioids in migraine.
引用
- Lipton RB, Buse DC, Friedman BW, et al. Characterizing opioid use in a US population with migraine: Results from the CaMEO study. Neurology. 2020. PMID: 32527971. doi:10.1212/WNL.0000000000009324
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。